ALT

1.3305.67%
WF

Wayne F. Pisano

Independent Director

Mr. Wayne F. Pisano, MBA, was Interim Chief Executive Officer at Oncolytics Biotech Inc. since June 24, 2024. He has been an Independent Director of Altimmune, Inc. since August 30, 2018. Mr. Pisano had been an Independent Director of Provention Bio, Inc. since April 2018 and had been its Independent Chairman since October 2019 until April 27, 2023. Mr. Pisano served as the Chief Executive Officer and President of VaxInnate Corporation from January 2012 to November 2016. Mr. Pisano has been an Director of Oncolytics Biotech Inc. since May 9, 2013. Mr. Pisano has been the Chairman of Oncolytics Biotech Inc. since June 08, 2015. Mr. Pisano serves as a Member of Advisory Board to Vaxess Technologies, Inc. Mr. Pisano rich experience as a pharmaceutical industry executive and was recognized in 2010 as Pharma Executive of the Year by the World Vaccine Congress. He served as President of Pirus Biological & Vaccine Consulting. He has depth of experience across the spectrum of commercial operations, public immunization policies and pipeline development. He served as Chief Executive Officer and President of Sanofi Pasteur Pty Ltd. He served as President and Chief Executive Officer of Sanofi Pasteur Inc. from August 1, 2007 to 2011. He has served as a Board director for AERAS a non-profit organization with a focus on TB vaccine development. He served as the Chief Executive Officer and President of Sanofi Pasteur SA since May 2008. He served as Chief Executive Officer and President of Sanofi Pasteur Limited, a division of Sanofi-Aventis since August 1, 2007. He served as Senior Vice President of Vaccines of Sanofi-Aventis since August 1, 2007. He served as Senior Vice President of Commercial Operations of Sanofi Pasteur Inc. since 2003 and as its Senior Vice President of Global Commercial Operations and Corporate Strategy since 2006. He had overall responsibility for sanofi pasteur's three business units including sanofi pasteur US, sanofi pasteur Canada and sanofi pasteur International. During his tenure as CEO, Mr. Pisano bolstered the Sanofi Pasteur pipeline with the acquisitions of Acambis PLC, a biotech based in Boston in 2008 and Shantha Biotechnics, a highly regarded Indian vaccine company in 2010. He joined Sanofi Pasteur in May 1997 as Vice President of US Marketing and then served as Senior Vice President of US Marketing and Sales since April 1998. He was instrumental in reorganizing the Marketing & Sales Department as well as developed strategies and tactics to meet the challenges of sanofi pasteur USA product line and market base. Since 2002, Mr. Pisano served as an Executive Vice President of Sanofi Pasteur North America. He is a Member of the Joint Venture Board and the Canadian Board. He has been a Director of VaxInnate Corporation since April 1, 2012. He served as a Director of IMV Inc. from October 17, 2011 to April 1, 2021. He holds a Bachelor of Science in Biology from St. John Fisher College and an MBA degree in Marketing from the University of Dayton.

Positions